May 8, 2018 Synthetic Biologics Reports First Quarter 2018 Operational Highlights and Financial Results
April 26, 2018 Synthetic Biologics to Report First Quarter 2018 Operational Highlights and Financial Results on May 8, 2018
April 23, 2018 Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection
February 22, 2018 Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results
February 15, 2018 Synthetic Biologics to Report 2017 Year End Operational Highlights and Financial Results on February 22, 2018
